- Neumentix is a branded spearmint extract standardized for polyphenols. Published human trials have examined attention, working memory, reaction performance and sleep-related outcomes in specific groups.
- Two randomized, double-blind trials indexed by PubMed used 900 mg daily for 90 days in healthy, recreationally active adults. One examined cognitive domains and the other reactive agility. These are useful signals, but they do not establish treatment of cognitive disease.
- Neumentix is not caffeine. It should not be expected to produce caffeine's immediate alerting sensation, and a study lasting weeks cannot justify an “instant focus” promise.
What Neumentix is
Neumentix is a branded spearmint extract standardized for polyphenols. Published human trials have examined attention, working memory, reaction performance and sleep-related outcomes in specific groups.
The brand name helps identify the studied extract. It does not guarantee that every product contains the studied amount or that every user matches the trial participants.
What the human trials studied
Two randomized, double-blind trials indexed by PubMed used 900 mg daily for 90 days in healthy, recreationally active adults. One examined cognitive domains and the other reactive agility. These are useful signals, but they do not establish treatment of cognitive disease.
Some study authors were affiliated with the ingredient company. Funding and author affiliations do not automatically invalidate results, but they belong in the reader's assessment of replication and certainty.
How it differs from stimulant-style products
Neumentix is not caffeine. It should not be expected to produce caffeine's immediate alerting sensation, and a study lasting weeks cannot justify an “instant focus” promise.
Caffeine has a familiar acute effect but can also worsen sleep, anxiety, palpitations or dependence patterns in some people. The better choice depends on the outcome and the person's health context—not which ingredient sounds newer.
How it compares with Bacopa and Ginkgo
Bacopa trials typically evaluate particular extracts over weeks, while evidence and doses vary. For Ginkgo, the NCCIH reports no conclusive benefit for any health condition and no demonstrated prevention or slowing of dementia.
Ginkgo also deserves extra attention for bleeding risk and drug interactions. “Natural nootropic” is not a safety category.
How to evaluate a product containing Neumentix
Confirm that the label names the branded extract, states the daily amount and does not bury it in an undisclosed blend. Compare the amount and intended duration with the trials, then check all other ingredients separately.
Neumentix is an interesting ingredient with limited, emerging human evidence—not a proven treatment for memory loss. Transparent dosing and a realistic goal matter more than the logo on the label.
References and source notes
We link the public sources used for the health context on this page. A source about an ingredient does not prove that a finished supplement works.
- Randomized trial of spearmint extract and attention ↗900 mg daily for 90 days; healthy active adults.
- Randomized trial of spearmint extract and reactive agility ↗Human placebo-controlled trial and author affiliations.
- Systematic review of Bacopa randomized trials ↗Ingredient-level evidence in adults without dementia.
- NCCIH: Ginkgo usefulness and safety ↗Evidence limits, pregnancy and drug interactions.